Robert E. Bellet
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Cutaneous Melanoma Detection and Management
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 23
- Cancer Treatment and Pharmacology 9
- Cutaneous Melanoma Detection and Management 6
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- Michael J. Mastrangelo (19 shared papers)David Berd (10 shared papers)Giuseppe Fraschini (2 shared papers)R S Walters (2 shared papers)Vicente Valero (2 shared papers)Leticia Esparza (1 shared paper)Howard A. Burris (4 shared papers)Frankie A. Holmes (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer (5 papers)JNCI Journal of the National Cancer Institute (1 paper)American Journal of Ophthalmology (1 paper)Annals of the New York Academy of Sciences (1 paper)
- Partner nations
- United StatesUnited KingdomNew Zealand
In The Last Decade
Robert E. Bellet
35 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 87
- Oncology 940
- Cancer Research 268
- Dermatology 105
- Immunology 211
- Ophthalmology 58
Countries citing papers authored by Robert E. Bellet
This map shows the geographic impact of Robert E. Bellet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Bellet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Bellet more than expected).
Fields of papers citing papers by Robert E. Bellet
This network shows the impact of papers produced by Robert E. Bellet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Bellet. The network helps show where Robert E. Bellet may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Bellet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 333 | |
| 2 | 1995 | 280 | |
| 3 | 1992 | 120 | |
| 4 | 1989 | 98 | |
| 5 | Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma. | 1987 | 85 |
| 6 | 1976 | 61 | |
| 7 | 1975 | 57 | |
| 8 | 1979 | 50 | |
| 9 | 1977 | 49 | |
| 10 | 1980 | 48 | |
| 11 | 2008 | 46 | |
| 12 | Phase I study of 5-azacytidine (NSC-102816) . | 1972 | 39 |
| 13 | 1977 | 33 | |
| 14 | 1973 | 31 | |
| 15 | 1977 | 18 | |
| 16 | Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study). | 1973 | 17 |
| 17 | 2007 | 16 | |
| 18 | 1999 | 14 | |
| 19 | 1987 | 14 | |
| 20 | 1993 | 14 |
About Robert E. Bellet
Robert E. Bellet is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Immunotherapy and Immune Responses (7 papers), Cutaneous Melanoma Detection and Management (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer therapeutics and mechanisms (4 papers), Cancer, Lipids, and Metabolism (3 papers), CAR-T cell therapy research (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Oncology (940 citations), Cancer Research (268 citations), Dermatology (105 citations), Immunology (211 citations) and Ophthalmology (58 citations). Robert E. Bellet has collaborated with scholars based in United States, United Kingdom and New Zealand. Frequent co-authors include Michael J. Mastrangelo, David Berd, Giuseppe Fraschini, R S Walters, Vicente Valero, Leticia Esparza, Howard A. Burris, Frankie A. Holmes, Gabriel N. Hortobágyi and Aman U. Buzdar. Their work appears in journals such as Journal of Clinical Oncology, Cancer, JNCI Journal of the National Cancer Institute, American Journal of Ophthalmology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.